telehealth glp-1 crackdown news today The FDA is cracking down on ‘misleading’ compounded GLP-1s from companies., Compounded weight loss drugs are not FDA-approved, which means the agency does not review their safety, The growing availability of compounded

Did your health care provider help you when they prescribed this drug or was it pretty much here's the drug, you're on your own

On the other hand, tirzepatide for long-term weight loss has shown similar success

Their inventor, Professor Kieran Clarke, sees no real advantages for the average athlete over glucose supplements and drinks

In addition to reductions in body weight, abdominal fat and liver fat, retatrutide treatment was associated with improvements in insulin sensitivity, lipid metabolism and adipocyte hormones

A.Abdel-RaheS

TRICARE Prime and Select users retain this coverage with prior authorization, and all beneficiaries still receive GLP-1 coverage when the drug is prescribed for Type 2 diabetes